27 studies found for:    LY2216684
Show Display Options
RSS Create an RSS feed from your search for:
LY2216684
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Study to Evaluate the Effect of Genotype on LY2216684
Condition: Depressive Disorder, Major
Interventions: Drug: LY2216684;   Drug: Quinidine
2 Completed A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects
Condition: Depressive Disorder, Major
Interventions: Drug: LY2216684;   Drug: Activated Charcoal
3 Completed A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Sertraline
4 Completed A Study to Evaluate the Effect of Food on LY2216684
Condition: Depressive Disorder, Major
Intervention: Drug: LY2216684
5 Completed A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Fluoxetine
6 Completed A Study to Evaluate the Effect of Clarithromycin on LY2216684
Condition: Depressive Disorder, Major
Interventions: Drug: LY2216684;   Drug: Clarithromycin
7 Completed A Study of LY2216684 in Healthy Subjects
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: LY2216684 Placebo;   Drug: Alcohol Placebo containing beverage;   Drug: Alcohol containing beverage
8 Completed A Study of LY2216684 in Healthy Subjects Receiving Albuterol or Propanolol
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: albuterol;   Drug: propranolol;   Drug: placebo for LY2216684;   Drug: placebo for albuterol;   Drug: placebo for propranolol
9 Completed A Study of LY2216684 in Healthy Females
Condition: Depressive Disorder, Major
Interventions: Drug: LY2216684;   Drug: Ortho Cyclen;   Drug: Placebo
10 Completed A Study of LY2216684 and Theophylline in Healthy Subjects
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Theophylline
11 Completed A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo
12 Completed A Study of the Effect of LY2216684 on Lorazepam
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo;   Drug: Lorazepam
13 Completed A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel
Condition: Major Depressive Disorder
Interventions: Drug: Clopidogrel;   Drug: LY2216684 + clopidogrel
14 Completed A Study of LY2216684 and Digoxin in Healthy Subjects
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Digoxin
15 Completed A Study of LY2216684 and Warfarin in Healthy Subjects
Condition: Major Depressive Disorder
Interventions: Drug: Warfarin;   Drug: LY2216684
16 Completed A Study of LY2216684 in Subjects With Impaired Hepatic Function
Condition: Depressive Disorder, Major
Intervention: Drug: LY2216684
17 Completed A Study of LY2216684 in Patients With Major Depression Disorder
Condition: Major Depressive Disorder
Intervention: Drug: LY2216684
18 Active, not recruiting A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: LY2216684
19 Completed A Study in Prevention of Re-emergence of Depression Symptoms
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo
20 Completed A Safety Study in Patients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Intervention: Drug: LY2216684

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
Indicates status has not been verified in more than two years